XBiotech XBIT
NASDAQ XBIT
$2.00 -0.12 (-5.66%)
At close: Oct 19, 2026 · 4:00 PM EDT

XBiotech (XBIT) Short-term Investments (2022 - 2023)

Updated

XBiotech's Short-term Investments came in at $61.38 million for Q2 2023, up 2.0% from the prior quarter.

Analysis

XBiotech (XBIT) Short-term Investments (2022 - 2023) Analysis & Trends

At the end of FY2022, XBiotech's Short-term Investments was $60.17 million.

  • Business Quant data shows XBIT's Short-term Investments at $60.18 million (Q1 2023), $60.17 million (Q4 2022) and $59.53 million (Q3 2022) in the three quarters before Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn
10 XBiotech 60.98 Mn -474.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 61.38 Mn
Mar 31, 2023 60.18 Mn
Dec 31, 2022 60.17 Mn
Sep 30, 2022 59.53 Mn
API Access

XBiotech Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=XBIT&period=max&api_key=YOUR_API_KEY